Agenda
Day 1 - Wednesday, 26 June
8:00 – 8:45
Registration open & coffee
GENERAL SESSION
FUTURE THERAPEUTIC APPROACHES: PRECISION MEDICINE, REGENERATIVE MEDICINE AND NEW MODALITIES
08:45 - 09:00
Opening
Opening
1
OpeningMarek Tyl, Health Horizons
9:00 – 9:20
Keynote
Keynote
1
Turning science into medicine: Power of precision medicineDr. Stefan Platz, AstraZeneca
09:20 – 10:00
Moderated discussion
Moderated discussion
1
On the way towards regenerative medicine: from cell therapy to tissue and organ replacementProf. Alicia El-Haj, University of Birmingham Melanie Matheu, Prellis Biologics, Inc.Dmitry Kuzmin, 4BIO CapitalRonald Li,Ming Wai Lau Center for Reparative Medicine, Karolinska Institute, Novoheart Lorenz Mayr, GE Healthcare Life Sciences
10:20 - 10:45
Fireside chat
Fireside chat
1
CRISPR, gene editing and what's beyondLisa Melton, Nature BiotechnologySteve Rees, AstraZenecaAlasdair Russell, Cancer Research UK
10:45 - 11:05
COFFEE BREAK
SESSION 1
CO-CREATION BETWEEN DISCIPLINES AND STAKEHOLDERS
SESSION 2
TRANSFORMING BRAIN AND CNS HEALTH
11:05 – 11:25
Keynote
Keynote
1
Open science and open innovationHitesh Sanganee, AstraZeneca
2
Future development in neurodegenerative diseases and mood disorder treatmentsJohn Isaac, Johnson & Johnson Innovation
11:25 – 12:05
Moderated discussion
Moderated discussion
1
Examples of co-creation to innovate and improve healthcare – Cambridge vs the rest of the worldSabine Jaccaud, AstraZenecaMaría Aguirre Rueda, Ministry for Health, BasqueHermann Hauser, Amadeus CapitalOlivier Nosjean, Servier Zoe McDougall, Oxford NanoporeMatti Ahlqvist, AstraZenecaTony Kouzarides, Milner Therapeutics Institute
12:05 – 12:20
Fire side chat
Fire side chat
1
Co-creation at the interface of computing and biologyHermann Hauser, Amadeus CapitalJeanette Walker, Cambridge Science Park
2
[12:05 - 12:20] The Human Brain Project Jan G. Bjaalie, University of Oslo[12:20 - 12:35] Treating persistent painPeter McNaughton, King's College London
GENERAL SESSION
PATIENT-CENTRIC INNOVATION
12:20 - 12:35
Fireside chat
Fireside chat
1
Can expensive innovation be accessible and save cost?Steven Altschuler, Spark Therapeutics Paul Brackley, Cambridge Independent
12:35 - 13:15
Moderated discussion
Moderated discussion
13:15 - 13:30
Keynote
Keynote
1
The future of digital healthChris Lowe,University of Cambridge
13:30 - 14:30
LUNCH
SESSION 3
DIGITAL DISRUPTORS: AI AND DATA IN HEALTHCARE
SESSION 4
DRUGGING DIFFICULT TARGETS
14:30 - 14:50
Keynote
Keynote
1
Data in healthcare: from drug discovery to clinical analysisKenji Tekada, Microsoft Research
2
Protein misfolding and diseaseTuomas Knowles, University of Cambridge
14:50 - 15:10
Science frontiers keynote
Science frontiers keynote
1
Digital health and data in the pharmaceutical industryAndrew Fried, IBM
2
Systematic ways of targeting difficult drug targetsMalcolm Weir, Sosei-Heptares
15:10 - 15:50
Moderated Discussion
Moderated Discussion
1
Machine learning: from genomics and novel targets to better medicines and diagnosesAndrew Fried, IBMAlex Zhavoronkov, Insilico MedicineMaria Chatzou, Lifebit BiotechSlavé Petrovski, AstraZenecaParminder Ruprah, GTN
15:50 - 16:05
Short Keynote
Short Keynote
1
Machine learning and advance tissue imaging analysisRichard Goodwin, AstraZeneca
2
[16:00 - 16:20] Targeted protein degradation in drug discoveryAlessio Ciulli, University of Dundee
16:20 - 16:40
COFFEE BREAK
SESSION 5
INTEGRATIVE MEDICINE: PUTTING THE PATIENT IN THE CENTRE
SESSION 6
NANOMEDICINE AND NANOTECHNOLOGIES
16:40 - 17:00
Keynote
Keynote
1
Convergence of food and healthIan Charles, Quadram Institute
2
Nanotechnologies for the health industryLars Montelius, Lund University[17:00 - 17:15] Delivering medicine with nanotechnologySir Mark Welland, University of Cambridge
17:00 - 17:40
Moderated Discussion
Moderated Discussion
1
Microbiome and the merging of food and healthcareIan Charles, Quadram InstituteBeatriz Silva-Lima, Universidade de LisboaRobert Tansley, CICTrevor Lawley, MicrobioticaDirk Hadrich, European CommissionLaura Moore, NellCarlos Montes, Food Academy
17:40 - 17:55
Science frontiers Keynote
Science frontiers Keynote
1
Leveraging the microbiome for precision diagnosis and treatmentTrevor Lawley, Microbiotica
2
17:55 - 18:10
Fireside Chat
Fireside Chat
1
What is your scientific narrative – integrating KOLs opinions with customer opinionsGunjan Bhardwaj, Innoplexus
18:10
COCKTAILS
Day 2 - Thursday, 27 June
08:00
Registration open & coffee
GENERAL SESSION
HOW TO REVOLUTIONISE CLINICAL TRIALS
09:00 - 09:20
Keynote
Keynote
1
Demonstrating value - the necessary tension between controlled vs uncontrolled clinical trialsRory O'Connor, Pfizer
09:20 - 10:00
Moderated Discussion
Moderated Discussion
1
Translating controlled data into populational value - how controlled trials can be used to predict the response in normal patient populationsMartin Landray,Health Data Research UKJoanne M. Hackett,Genomics EnglandSolange Corriol-Rohou, AstraZenecaJanet Valentine, Clinical Practice Research DatalinkTomasz Sablinski, Transparency Life SciencesBeatriz Silva-Lima, Universidade de LisboaHans Constandt, Ontoforce
10:00 - 10:15
Fireside chat
Fireside chat
1
Clinical data security, integrity and quality - learnings from the financial industryJason Potts, RMIT UniversityAnn Taylor, Chief Medical Officer, AstraZenecaAna Perales, Barclays UK Ventures
GENERAL SESSION
MANAGING CANCER
10:15 - 11:30
Keynote
Keynote
1
Cancer as a managable diseaseSir Leszek Borysiewicz, Cancer Research UK
10:30 - 11:10
Moderated Discussison
Moderated Discussison
1
Prevention, early detection and future therapies in oncologySir Leszek Borysiewicz, Cancer Research UKSteve Jackson, Gurdon InstituteJohn Cassidy, Cambridge Cancer GenomicsCesare Spadoni, aPODD FoundationPatrizia Paterlini-Bréchot, Paris Descartes UniversitySusan Critchlow, Oncology, AstraZeneca
11:10 - 11:25
Fireside Chat
Fireside Chat
1
Advances in cancer treatment and early diagnosisJane Grogan, GenentechAnna Williamson, Roche Pharma Partnering
11:25 - 11:45
COFFEE BREAK
STARTUP PITCHING
11:45 - 13:30
13:30 - 14:30
LUNCH
SESSION 7
THE COST OF HEALTH - NOVEL APPROACHES TO FUNDING INNOVATION
SESSION 8
VIRTUAL REALITY IN CLINICAL PRACTICE AND CARE PROVISION
14:30 - 14:45
Keynote
Keynote
1
Funding alliancesHarren Jhoti, Astex Pharmaceuticals
2
[14:30 - 14:35] Introductury talks
14:45 - 15:30
Moderated Discussion
Moderated Discussion
1
Partner to innovate: Evolving landscapes of healthcare innovation, new partnership models and investor profilesSonia Benhamida,DNB Bank, HealthcareEd Rayner, ArixPaul-Peter Tak, Kintai Therapeutics Inc.Pavithra Sundaresan, Johnson & Johnson InnovationIan Tomlinson, Apollo TherapeuticsMakoto Ohori, Astellas Pharma Inc.
2
[14:35 - 15:45] Challenges and opportunities of Applied VR in HealthcareRobert Fine, IVRHAFran Ayalasomayajula, HPAmy Hedrick, Cleanbox TechnologyRichard Vincent, FundamentalVR
15:30 - 15:45
Fireside Chat
Fireside Chat
1
Supporting healthcare innovation with new funding modelsPaul-Peter Tak, Kintai Therapeutics Inc.Robert Tansley - Operating Partner, Cambridge Innovation Capital
COFFEE BREAK
SESSION 9
TOWARDS HEALTHY LONGEVITY
SESSION 10
START-UP SHOWCASE
16:05 -16:25
Keynote
Keynote
1
Ageing as a new therapy areaAubrey de Grey, SENS Research Foundation
16:25 - 17:05
Moderated Discussion
Moderated Discussion
1
Live long and prosper: Extending lifespan and healthspanDaniel Ives, Shift Bioscience LtdAlexandra Bause, Apollo VenturesJane McDermott, Centre for Ageing BetterBernardo Lemos, Harvard T.H. Chan School of Public HealthMarc Ramis Castelltort, Senolytic Therapeutics Inc.Attila Csordas, AgeCurve Limited
17:05 - 17:25
Science frontiers keynote
Science frontiers keynote
1
Ribosomal DNA and novel biomarkers of ageingBernardo Lemos, Harvard T.H. Chan School of Public Health
17:25 - 17:45
Fireside chat
Fireside chat
1
Ageing start-up company challengesAubrey de Grey, SENS Research FoundationAlexandra Bause, Apollo Ventures
STARTUP PITCHING WINNER ANNOUNCEMENT
17:50 - 18:05
18:05
COCKTAIL